Suppr超能文献

阿克拉霉素A和柔红霉素衍生物的致突变性。

Mutagenicity of aclacinomycin A and daunomycin derivatives.

作者信息

Umezawa K, Sawamura M, Matsushima T, Sugimura T

出版信息

Cancer Res. 1978 Jun;38(6):1782-4.

PMID:348304
Abstract

An antitumor antibiotic aclacinomycin A, was nonmutagenic in a Salmonella test, but its derivative, N-demethylaclacinomycin A, was mutagenic. Similarly, 1-deoxypyrromycin, a hydrolysis product of aclacinomycin A, was nonmutagenic, but N-demethyl-1-deoxypyrromycin was mutagenic. Daunomycin was highly mutagenic, but N-methyldaunomycin showed only weak mutagenicity, and N-dimethyldaunomycin was nonmutagenic. The aglycones of aclacinomycin A and daunomycin were not mutagenic. Thus, the amino moiety of anthracycline glycosides is concluded to be essential for mutagenesis.

摘要

抗肿瘤抗生素阿克拉霉素A在沙门氏菌试验中无致突变性,但其衍生物N-去甲基阿克拉霉素A具有致突变性。同样,阿克拉霉素A的水解产物1-脱氧吡咯霉素无致突变性,但N-去甲基-1-脱氧吡咯霉素具有致突变性。柔红霉素具有高度致突变性,但N-甲基柔红霉素仅表现出微弱的致突变性,而N-二甲基柔红霉素无致突变性。阿克拉霉素A和柔红霉素的苷元无致突变性。因此,得出结论,蒽环类糖苷的氨基部分对于诱变是必不可少的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验